Alice P. Chen

机构：National Institutes of Health, University of the Potomac, Dana-Farber Cancer Institute, National Cancer Institute, System Biosciences (United States), National Cancer Institute · ORCID：0000-0002-1426-853X

发表论文 753 篇 · 总被引 19590 次 · h-index 68

代表论文

• Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials (2026 · Annals of Surgical Oncology · 被引 3)
• SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST) (2026 · Clinical Cancer Research · 被引 3)
• Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E (2026 · JCO Precision Oncology · 被引 2)
• Abstract 1662: GSPT1 degrader antibody conjugate, BLB-201, for the treatment of high-risk acute myeloid leukemia (2026 · Cancer Research · 被引 1)
• Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2 (2026 · Clinical Cancer Research · 被引 1)
• A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors (2025 · Cancer Chemotherapy and Pharmacology · 被引 1)